BIOMAT Database Logo BIOMAT Database Logo

Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation. 2021

Garrett S Booth, and Bipin N Savani, and Amelia A Langston
The Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

UI MeSH Term Description Entries
D012010 Red-Cell Aplasia, Pure Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production. Aplasia Pure Red Cell,Erythrocyte Aplasia,Pure Red-Cell Aplasia,Aplasia, Erythrocyte,Aplasia, Pure Red-Cell,Aplasias, Erythrocyte,Erythrocyte Aplasias,Pure Red Cell Aplasia,Pure Red-Cell Aplasias,Red Cell Aplasia, Pure,Red-Cell Aplasias, Pure
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell

Related Publications

Garrett S Booth, and Bipin N Savani, and Amelia A Langston
[Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
September 2005, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Garrett S Booth, and Bipin N Savani, and Amelia A Langston
Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
February 2002, Zhongguo shi yan xue ye xue za zhi,
Garrett S Booth, and Bipin N Savani, and Amelia A Langston
Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
July 2018, Blood transfusion = Trasfusione del sangue,
Garrett S Booth, and Bipin N Savani, and Amelia A Langston
No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation.
May 2019, Bone marrow transplantation,
Garrett S Booth, and Bipin N Savani, and Amelia A Langston
Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation.
January 2022, Frontiers in immunology,
Garrett S Booth, and Bipin N Savani, and Amelia A Langston
Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation.
January 1990, Acta haematologica,
Garrett S Booth, and Bipin N Savani, and Amelia A Langston
Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation.
January 1990, Blood,
Garrett S Booth, and Bipin N Savani, and Amelia A Langston
Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation.
June 2014, Transfusion medicine (Oxford, England),
Garrett S Booth, and Bipin N Savani, and Amelia A Langston
[Pure red cell aplasia following ABO-incompatible allogeneic hematopoietic stem cell transplantation].
April 2008, Zhongguo shi yan xue ye xue za zhi,
Garrett S Booth, and Bipin N Savani, and Amelia A Langston
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.
March 2013, British journal of haematology,
Copied contents to your clipboard!